In adults there was a small difference in asthma symptoms measured by using the Asthma Symptom Utility Index ( M - P , 0.06 ; 95 % CI , 0.01 to 0.11 ; P < .01 ) and in nasal symptoms ( sinus symptom score M - P , -3.82 ; 95 % CI , -7.19 to -0.45 ; P = .03 ) but no difference in asthma quality of life , lung function , or episodes of poorly controlled asthma in adults assigned to mometasone versus placebo .